Sensirion founders win Entrepreneur of the Year Award
Recognised for their innovation, flexibility and willingness to take risks
The Award is given to successful entrepreneurs who combine personal commitment and risk-taking to help strengthen the competitiveness of the Swiss economy.
Sensirion was set up in 1998 as a spin-off from ETH Zurich and has since established itself as a leading hi-tech company developing humidity- and temperature sensors, mass flow controllers, flow sensors for gases and fluids, as well as differential pressure sensors.
Headquartered near Zurich, it now employs more than 200 people and also has offices in the US, Japan, South Korea and China.
Describing Sensirion as ‘solid, consistent, innovative, cosmopolitan and still modest’, the judges also said the firm’s distinctive corporate culture had contributed to its success.
‘Winning the Entrepreneur of the Year 2010 Award is for us, both confirmation and motivation to serve our customers time and again with innovative and requirement-oriented sensor solutions,’ said Lechner.
Bruno Chiomento, chief executive of Ernst & Young Switzerland, said despite the difficult economic environment, entrepreneurship in Switzerland is in full bloom. He said the winners had been successful because of their innovation, flexibility and willingness to take risks.
You may also like
Manufacturing
Domino demonstrates an integrated approach to next-generation coding at Interpack 2026
At Interpack 2026, Domino Printing Sciences (Domino) will focus on the key challenges manufacturers face as variable data printing enters a new era shaped by 2D codes, intelligent automation, sustainability, and growing traceability demands. Domino specialists will be available throughout the show to highlight integrated solutions designed to work together on the factory floor – developed in collaboration with key industry partners to help to reduce complexity, risk, and operational friction for manufacturers
Manufacturing
Bristol Myers Squibb licenses Lonza ADC linker-payload technology for undisclosed target
BMS has secured exclusive access to Lonza’s SYNtecan linker-payload platform, alongside GlycoConnect and HydraSpace technologies, to advance development of an antibody-drug conjugate against an undisclosed target
Manufacturing
Former Catalent Chair and CEO George Fotiades joins eXmoor Pharma board as Chair
Angela Osborne steps back from operational duties and continues as Founder and Board Director, providing strategic continuity as eXmoor builds the leadership depth to support its expanding integrated CDMO model